(A) Representative immunoblot images of EMD-treated or -untreated groups. Effect of 10 or 60 min of EMD treatment on Akt phosphorylation in gingival fibroblasts maintained at a control (Cont) or high glucose (HG) concentration. (B) Akt phosphorylation was quantified via densitometric analysis and expressed as a percentage of phosphorylation in EMD-untreated groups. Data are presented as mean ± SD values. *p Vegf was measured via real-time polymerase chain reaction (PCR) in the four groups (control glucose medium without EMD, Cont-; control glucose medium with EMD for 3–12 h, Cont+; high glucose medium without EMD, HG-; and high glucose medium with EMD for 3–12 h, HG+). Data are presented as mean ± SD values. *p Vegf with/without wortmannin ...
<p>Western blotting analysis of AKT and ERK1/2 activation (p-AKT; p-ERK1/2). MT1-MMP-expressing Tet-...
<p>A total of 10<sup>6</sup> THP1 or Raji cells/well were cultured in the presence of 20ng/ml EGF an...
<p>MA-10 cells were treated without or with FGF9 (50 ng/ml) for the indicated times. The expression ...
<p>(A) Effect of insulin on phosphorylation of Akt and Erk1/2 in gingival fibroblasts from control a...
<p>(<b>A</b>) AKR-2B and NIH 3T3 fibroblast were treated with TGF-β (2 ng/ml) for times ranging from...
<p>A. Analysis of serum-stimulated phosphorylation of AKT and ERK1/2 as well as total AKT and ERK1/2...
<p>(A) HeLa and IMR-90 cells were continuously exposed to a 6 mT ELF-EMF for 1, 6, 12, 24 h and then...
<p>(A) Wound healing assay was performed to analyze effects of HG, 100 ng/mL of bFGF (b) and 50 nM o...
<p>For AKT and ERK1/2 phosphorylation, cells were treated with FGF-2 (10 ng/ml) and harvested at (2,...
<p>SBOT3.1 and MPSC1 cells were treated with 50 ng/ml EGF for the indicated durations. Phosphorylati...
<p>(A) Western blot analysis of phospho-Erk1/2 MAPKs in wt or p130Tg organoids stimulated with EGF a...
<p>OFF HeLa NEU3-HA-GFP cells were plated and switched ON for the indicated time periods. 24 h befor...
<p>(<b>A</b>) AKR-2B fibroblasts were treated with the PI3K inhibitor LY294002 or MEK inhibitor U012...
<p>70% confluent fibroblasts were pretreated with SB202190 or vehicle DMSO for 1 h and cultured on n...
<p>(A) Western blotting analysis of ERK phosphorylation (pERK) and total ERK expression (ERK) in C2C...
<p>Western blotting analysis of AKT and ERK1/2 activation (p-AKT; p-ERK1/2). MT1-MMP-expressing Tet-...
<p>A total of 10<sup>6</sup> THP1 or Raji cells/well were cultured in the presence of 20ng/ml EGF an...
<p>MA-10 cells were treated without or with FGF9 (50 ng/ml) for the indicated times. The expression ...
<p>(A) Effect of insulin on phosphorylation of Akt and Erk1/2 in gingival fibroblasts from control a...
<p>(<b>A</b>) AKR-2B and NIH 3T3 fibroblast were treated with TGF-β (2 ng/ml) for times ranging from...
<p>A. Analysis of serum-stimulated phosphorylation of AKT and ERK1/2 as well as total AKT and ERK1/2...
<p>(A) HeLa and IMR-90 cells were continuously exposed to a 6 mT ELF-EMF for 1, 6, 12, 24 h and then...
<p>(A) Wound healing assay was performed to analyze effects of HG, 100 ng/mL of bFGF (b) and 50 nM o...
<p>For AKT and ERK1/2 phosphorylation, cells were treated with FGF-2 (10 ng/ml) and harvested at (2,...
<p>SBOT3.1 and MPSC1 cells were treated with 50 ng/ml EGF for the indicated durations. Phosphorylati...
<p>(A) Western blot analysis of phospho-Erk1/2 MAPKs in wt or p130Tg organoids stimulated with EGF a...
<p>OFF HeLa NEU3-HA-GFP cells were plated and switched ON for the indicated time periods. 24 h befor...
<p>(<b>A</b>) AKR-2B fibroblasts were treated with the PI3K inhibitor LY294002 or MEK inhibitor U012...
<p>70% confluent fibroblasts were pretreated with SB202190 or vehicle DMSO for 1 h and cultured on n...
<p>(A) Western blotting analysis of ERK phosphorylation (pERK) and total ERK expression (ERK) in C2C...
<p>Western blotting analysis of AKT and ERK1/2 activation (p-AKT; p-ERK1/2). MT1-MMP-expressing Tet-...
<p>A total of 10<sup>6</sup> THP1 or Raji cells/well were cultured in the presence of 20ng/ml EGF an...
<p>MA-10 cells were treated without or with FGF9 (50 ng/ml) for the indicated times. The expression ...